Using risk factors to predict human papillomavirus infection: Implications for targeted vaccination strategies in young adult women

Vaccine

Volumn 26, Issue 8, 2008, Pages 1111-1117

  Dempsey, Amanda F ^a   Gebremariam, Achamyeleh ^a   Koutsky, Laura A ^b   Manhart, Lisa ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Human papillomavirus; Risk factors; Vaccines

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; DATA ANALYSIS; FEASIBILITY STUDY; FEMALE; HUMAN; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEXUAL BEHAVIOR; VACCINATION; VERRUCA VULGARIS; WART VIRUS;

ADOLESCENT; ADULT; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; RISK-TAKING; SENSITIVITY AND SPECIFICITY;

EID: 39149119641     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.11.088     Document Type: Article

References (25)

1. U.S. Food and Drug Administration. Product approval information-licensing action, Gardasil; 2006. Accessed August 1, 2006 at http://www.fda.gov/cber/products/hpvmer060806qa.htm.
2. Markowitz L.E., Dunne E.F., Saraiya M., Lawson H.W., Chesson H., and Unger E.R. Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 56 RR-2 (2007) 1-24
3. Centers for Disease Control and Prevention. VFC vaccine price list. Accessed August 22, 2007 at http://www.cdc.gov/nip/vfc/cdc_vac_price_list.htm.
4. Lee G.M., Santoli J.M., Hannan C., Messonnier M.L., Sabin J.E., Rusinak D., et al. Gaps in vaccine financing for underinsured children in the United States. JAMA 298 6 (2007) 638-643
5. Park M.J., Paul Mulye T., Adams S.H., Brindis C.D., and Irwin Jr. C.E. The health status of young adults in the United States. J Adolesc Health 39 3 (2006) 305-317
6. Collins S, Schoen, C, Kriss, JL, Doty, MM, Mahato, B. Rite of passage? Why young adults become uninsured and how new policies can help. In: Commonwealth fund, issue brief; 2007. Accessed August 13, 2007 at http://www.commonwealthfund.org/usr_doc/Collins_riteofpassage2007_1049_i b.pdf?section=4039.
7. Financing vaccines in the 21st century: assuring access and availability. Washington, DC: National Academic Press; 2004.
8. Saslow D., Castle P.E., Cox J.T., Davey D.D., Einstein M.H., Ferris D.G., et al. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin 57 1 (2007) 7-28
9. Hildesheim A., Herrero R., Wacholder S., Rodriguez A.C., Solomon D., Bratti M.C., et al. Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA 298 7 (2007) 743-753
10. Udry J.R. The National Longitudinal Study of Adolescent Health (Add Health), Waves I & II, 1994-1996 (1998), Carolina Population Center, University of North Carolina, Chapel Hill, NC
11. Resnick M.D., Bearman P.S., Blum R.W., Bauman K.E., Harris K.M., Jones J., et al. Protecting adolescents from harm. Findings from the National Longitudinal Study on Adolescent Health. JAMA 278 10 (1997) 823-832
12. Manhart L.E., Holmes K.K., Koutsky L.A., Wood T.R., Kenney D.L., Feng Q., et al. Human papillomavirus infection among sexually active young women in the United States: Implications for developing a vaccination strategy. Sex Transm Dis 33 8 (2006) 502-508
13. The Add Health Biomarkers Team. Biomarkers in Wave III of the Add Health Study. http://www.cpc.unc.edu/projects/addhealth/files/biomark.pdf, 2003.
14. Burk R.D., Ho G.Y., Beardsley L., Lempa M., Peters M., and Bierman R. Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women. J Infect Dis 174 4 (1996) 679-689
15. Tarkowski T.A., Koumans E.H., Sawyer M., Pierce A., Black C.M., Papp J.R., et al. Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population. J Infect Dis 189 1 (2004) 46-50 [Epub. December 22, 2003]
16. Wheeler C.M., Parmenter C.A., Hunt W.C., Becker T.M., Greer C.E., Hildesheim A., et al. Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico student health center. Sex Transm Dis 20 5 (1993) 286-289
17. Brown D.R., Shew M.L., Qadadri B., Neptune N., Vargas M., Tu W., et al. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 191 2 (2005) 182-192 [Epub. December 10, 2004]
18. Ho G.Y., Bierman R., Beardsley L., Chang C.J., and Burk R.D. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338 7 (1998) 423-428
19. Winer R.L., Lee S.K., Hughes J.P., Adam D.E., Kiviat N.B., and Koutsky L.A. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 157 3 (2003) 218-226
20. Harper D.M., Franco E.L., Wheeler C.M., Moscicki A.B., Romanowski B., Roteli-Martins C.M., et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 367 9518 (2006) 1247-1255
21. Brown D. HPV type 6/11/16/18 vaccine: First analysis of cross-protection against persistent infection, cervical intraepithelial neoplasia (CIN), and adenocarcinoma in situ (AIS) caused by HPV types in addition to 16/18. Abstract B-1729b: 47th Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, IL. Sept 19th, 2007.
22. Forslund O., Hansson B.G., Rymark P., and Bjerre B. Human papillomavirus DNA in urine samples compared with that in simultaneously collected urethra and cervix samples. J Clin Microbiol 31 8 (1993) 1975-1979
23. Jacobson D.L., Womack S.D., Peralta L., Zenilman J.M., Feroli K., Maehr J., et al. Concordance of human papillomavirus in the cervix and urine among inner city adolescents. Pediatr Infect Dis J 19 8 (2000) 722-728
24. Strauss S., Jordens J.Z., McBride D., Sonnex C., Edwards S., Desselberger U., et al. Detection and typing of human papillomavirus DNA in paired urine and cervical scrapes. Eur J Epidemiol 15 6 (1999) 537-543
25. Winer RL, Hughes JP, Feng Q, Kiviat NB, O-Reilly S, Koutsky LA. Risk of female human papillomavirus acquisition associated with a first male sex partner. J Infect Dis, 2007, in press.